Byron Hewett, has led healthcare and life science companies for more than 30 years, in multi-national firms, development-stage and start-up companies. Byron is a 4-time CEO, including being a founder of Brava Diagnostics (now LightDeck Diagnostics). Prior to Brava, Byron was CEO of SomaLogic, a life sciences tools company focused on biomarker discovery where he raised $240M in capital to fund the company’s growth. He served as Chairman and CEO of BioBehavioral Diagnostics, a start-up medical device company with the first FDA-cleared system for the assessment of ADHD. He served as CEO at Immunicon (NASDAQ: IMMC), the first FDA-cleared test for circulating tumor cells. He served in senior executive roles at Qiagen, Bayer Diagnostics, Chiron Diagnostics and Abbott Diagnostics.
Byron earned his MBA from Northwestern University’s J.L. Kellogg Graduate School of Management and a Bachelor’s of Science degree from the University of Virginia’s McIntire School of Commerce.